Celixir Company
Tissue specific regenerative medicine products, progenitor cells, phase 2 clinical trials. Devoted to discovering breakthrough medicines that change the standard of medical care for patients.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2009
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
1
Total Funding:
$2.6M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership